Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
A Phase 4, Double-Blind, Randomised, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of Adalimumab Used in Conjunction with Surgery in Subjects with Moderate to Severe Hidradenitis Suppurativa	AbbVie	Ongoing	Adalimumab	4	M15-574	King Faisal Specialist Hospital and Research Center (Riyadh)
"A PHASE 2/3, MULTICENTER, MULTINATIONAL,OPEN-LABEL STUDY TO EVALUATE THE EFFICACY ANDSAFETY OF ALXN1101 IN NEONATES WITH MOLYBDENUMCOFACTOR DEFICIENCY (MOCD) TYPE A"	Alexion	Ongoing	ALXN1101( Cyclic pyranopterin monophosphate monohydrobromide dihydrate)	2b	ALXN1101-MCD-202	King Fahad Medical City (Riyadh)
Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia	Janssen-Cilag International NV	Ongoing	canagliflozin	4	28431754DI	Specialized Medical Center (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah), Dallah Hospital (Riyadh), Almana Hospital (Jubail), Almouasa Hospital (Qatif), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh), Saudi German Hospital (Jeddah)
AfME Registry on GastroIntestinal Stromal Tumors (GIST) – A Retrospective Patients’ Profile Description and Evaluation of the Use of Tyrosine Kinase Inhibitors	Africa Middle East Cancer Intergroup (AMCI)	Ongoing	-	4	WI210066	King Fahad Medical City (Riyadh)
Clinical Effectiveness and Cost Implications of Patients Switching from Oral Antipsychotics to Long‑Acting Injectable Antipsychotics in the Treatment of Schizophrenia	Janssen-Cilag International NV	Ongoing	Consta	4	RRA-19315	Alamal Complex for mental health (Riyadh), King Fahad University Hospital (Al-Khobar)
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial	Sunnybrook Health Sience Center / KAIMRC	Ongoing	All SFDA already registered Antibiotics	4	CT 15/022	King Abdulaziz Medical City NG (Riyadh)
The Impact of Tigecycline Use on Fibrinogen Level in Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Patients. A Randomized Controlled Study	King Faisal Specialist Hospital & Research Center	Ongoing	Tigecycline	4	RAC#216103	King Faisal Specialist Hospital and Research Center (Riyadh)
Forxiga (dapagliflozin) Post Authorization Safety Study	AstraZeneca	Ongoing	Forxiga	4	D1690R0003	King Khalid University Hospital (Riyadh), Taibah University College of Medicine, Dr. Sulaiman Al-Habib Medical Group (Riyadh), Specialized Medical Center (Riyadh), International Medical Center (Jeddah), Dallah Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah)
ChaRactErization of patients following aCute venous thrOmboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the tReatment and secondarY prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice - RE-COVERY DVT/PE	Boehringer Ingelheim	Ongoing	Dabigatran etexilate	4	1160.188	King Salman Bin AbdulAziz Hospital
"CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions"	Novartis	Ongoing	Cosyntex	4	IN457A3404	King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)